Embolism and thrombosis of abdominal aorta

I9_EMBTHROAOR

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 I74.0
  • Hospital discharge: ICD-9 4440A
  • Hospital discharge: ICD-8 44400
  • Hospital discharge: excluded ICD-9 4440
  • Cause of death: ICD-10 I74.0
  • Cause of death: ICD-9 4440A
  • Cause of death: ICD-8 44400
  • Cause of death: excluded ICD-9 4440

2 out of 7 registries used, show all original rules.

71

4. Check minimum number of events

None

71

5. Include endpoints

None

71

6. Filter based on genotype QC (FinnGen only)

71

Control definitions (FinnGen only)

Control exclude
I9_DOAAC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
I74
Name in latin
Embolia aortae abdominalis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 71 25 46
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 65.98 62.34 67.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
69
Matched controls
689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I74.0
ICD-10 Finland
Embolism and thrombosis of abdominal aorta
+∞
75.4
58
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
153.7
40.6
40
6
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
+∞
14.0
13
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
21.5
12.5
18
11
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
+∞
10.7
10
*
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
+∞
9.6
9
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
+∞
9.6
9
*
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
+∞
9.6
9
*
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
+∞
7.4
7
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
+∞
7.4
7
*
4440A
ICD-9 Finland
Arterial embolism and thrombosis, Of abdominal aorta
+∞
7.4
7
*
I74.1
ICD-10 Finland
Embolism and thrombosis of other and unspecified parts of aorta
+∞
6.3
6
*
C01DA14
ATC
isosorbide mononitrate; oral
3.9
6.0
28
102

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
17
8.29
8.27
2.3
1.9
u/ml
0.3
0.5
—
6
8
(3007853) Bacteria identified in Skin by Aerobe culture
18
41
5.54
7.96
1.9
1.6
—
—
—
0
0
(3012544) pH of Venous blood
18
49
4.58
6.40
7.3
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
22
5.73
5.46
22.8
6.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
52
3.98
5.14
2.5
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
8
11.07
4.65
3.9
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
52
3.39
3.73
2.5
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
12
38
3.60
3.39
10.6
8.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
82
2.80
3.26
2.5
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
40
3.41
3.14
18.9
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
27
143
2.43
3.06
4.0
4.0
mg/mmol
29.6
7.5
0.82
18
93
(3012095) Magnesium [Moles/volume] in Serum or Plasma
18
78
2.75
3.05
3.4
3.6
mmol/l
0.8
0.8
0.85
18
73
(3023368) Bacteria identified in Blood by Culture
27
147
2.35
2.85
8.9
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
14
5.42
2.80
2.4
2.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
10
34
3.26
2.52
8.2
6.6
%
93.5
94.2
—
10
34
(3012516) Albumin [Mass/volume] in Urine
24
132
2.24
2.43
3.6
3.3
mg/l
165.4
526.9
0.34
16
85
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
36
3.07
2.31
2.4
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
25
143
2.15
2.29
6.2
4.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
37
2.98
2.21
1.7
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
25
3.47
2.17
2.8
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
20
114
2.05
1.80
3.3
2.8
e6/l
2.9
3.5
0.22
20
99
(3032080) INR in Blood by Coagulation assay
33
233
1.78
1.54
21.2
7.7
inr
1.5
1.3
—
6
71
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
38
2.56
1.52
1.7
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
28
190
1.78
1.48
2.3
2.2
nmol/l
81.9
75.6
0.35
23
160
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
36
263
1.75
1.48
16.7
5.9
mmol/l
1.2
1.2
1.43
29
215
(3022313) Gas panel - Capillary blood
6
22
2.88
1.47
2.3
3.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
9
43
2.25
1.36
1.2
3.5
e9/l
73.4
70.6
—
9
33
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
34
2.52
1.34
10.0
5.6
%
1.7
1.3
—
8
34
(3018405) Lactate [Moles/volume] in Arterial blood
6
24
2.63
1.33
4.3
2.8
mmol/l
1.0
1.2
—
6
24
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35
438
0.60
1.25
44.8
15.1
ml/min/173m2
63.7
72.1
1.25
30
354
(36304419) Bacteria [Presence] in Urine
21
138
1.74
1.21
5.0
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
25
173
1.69
1.20
4.4
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
51
2.12
1.18
6.5
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
30
2.48
1.16
2.3
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
8
41
2.07
1.13
1.1
2.6
g/l
66.3
67.2
—
8
35
(3049717) Cytology report of Urine Cyto stain
5
21
2.48
1.11
4.4
2.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
21
2.48
1.11
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
117
1.72
1.07
4.5
3.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
34
2.17
1.06
11.3
6.3
%
0.7
0.8
—
7
34
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
26
189
1.59
1.01
5.9
3.0
—
—
—
0
0
(3020891) Body temperature
6
27
2.33
0.96
9.3
3.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
42
2.02
0.92
2.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30
232
1.51
0.87
6.8
4.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
23
2.26
0.78
1.2
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
68
1.73
0.77
4.8
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
85
1.65
0.75
5.3
2.6
e6/l
0.9
1.7
—
8
49
(3003338) MCHC [Mass/volume]
30
364
0.70
0.73
55.3
19.5
g/l
326.1
332.5
2.31
30
359
(3002256) Pathology report gross observation
10
62
1.71
0.69
2.7
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
40
458
0.71
0.66
6.0
5.0
mmol/l
6.2
6.1
0.36
34
415
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
5
29
1.78
0.65
1.0
1.4
g/l
1.9
1.7
—
5
23
(3020564) Creatinine [Moles/volume] in Serum or Plasma
44
494
0.71
0.63
48.0
18.3
umol/l
114.7
82.7
1.41
44
494
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
21
0.00
0.61
0.0
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
36
1.73
0.58
1.2
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
36
1.73
0.58
5.7
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
21
163
1.41
0.57
4.2
2.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
6
39
1.59
0.54
2.8
1.7
nmol/l
376.0
416.4
—
6
32
(3022217) INR in Platelet poor plasma by Coagulation assay
9
64
1.46
0.54
38.8
23.2
—
1.3
—
0
6
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26
212
1.36
0.53
2.3
1.9
pmol/l
93.1
96.7
0.15
17
101
(1761868) Lipid panel - Serum or Plasma
10
142
0.66
0.53
3.9
3.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
13
171
0.71
0.46
3.3
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
32
1.60
0.43
8.0
2.4
%
0.6
0.7
—
5
32
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
190
0.73
0.43
2.7
4.4
%
25.3
21.6
—
7
95
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
33
1.55
0.42
8.0
2.4
%
2.1
1.3
—
5
33
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
238
1.29
0.42
7.6
3.8
ng/l
34.6
40.2
0.23
23
189
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
16
0.00
0.41
0.0
3.7
—
33.3
—
0
10
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
34
1.51
0.41
2.8
1.7
—
—
—
0
0
(3000492) Spirometry study
5
34
1.51
0.41
2.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
29
250
1.27
0.38
7.3
5.4
estimate
0.0
0.0
—
6
44
(3009261) Glucose [Presence] in Urine by Test strip
29
251
1.26
0.37
6.1
4.0
estimate
0.0
0.0
—
5
42
(3035350) Ketones [Presence] in Urine by Test strip
29
251
1.26
0.37
5.9
3.9
estimate
0.0
0.0
—
6
43
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
91
1.38
0.36
3.8
2.5
e6/l
0.2
0.6
—
7
54
(40761535) Cells panel - Urine sediment
6
43
1.43
0.36
4.8
3.2
—
—
—
0
0
(3019225) pH of Specimen
7
51
1.41
0.33
4.9
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
45
485
0.80
0.32
39.4
14.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
66
1.24
0.28
21.3
7.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
36
329
1.19
0.25
8.3
4.6
—
483.3
—
0
10
(4010399)
5
37
1.38
0.24
2.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
42
1.20
0.22
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
112
0.78
0.22
2.1
3.2
mmol/l
2.5
2.5
—
9
93
(21494755) Public health laboratory ask at order entry panel
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
214
1.18
0.21
3.9
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
1.7
—
106.9
—
0
14
(3041354) Potassium [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
1.7
—
4.0
—
0
14
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
7
57
1.25
0.19
3.4
4.2
ug/l
9.3
133.7
—
7
47
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
120
1.21
0.18
4.4
2.1
—
—
—
0
0
(3013512) EKG study
19
172
1.14
0.13
7.7
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
85
1.21
0.13
3.3
6.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
10
115
0.85
0.11
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
43
1.17
0.10
1.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
43
1.17
0.10
3.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
12
110
1.11
0.05
7.2
6.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
201
0.93
0.05
6.2
4.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
45
461
0.93
0.05
44.6
15.3
mg/l
38.9
26.4
1.32
40
377
(3021589) Normoblasts [#/volume] in Blood
21
201
1.06
0.03
25.2
10.0
e9/l
0.0
0.0
0.51
15
164
(3041096) Erythrocytes [Presence] in Urine by Automated
13
137
0.94
0.02
5.5
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
41
417
0.96
0.01
5.7
4.7
mu/l
1.6
2.0
1.31
35
368
(3009542) Hematocrit [Volume Fraction] of Blood
38
373
1.04
0.01
42.9
16.0
%
35.2
37.7
0.51
18
229
(3044889) 12 lead EKG panel
34
347
0.96
0.01
7.3
4.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
34
334
1.03
0.00
8.2
4.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
66
0.90
0.00
1.7
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
311.2
—
0
6
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
5.5
—
0
6
(4146454)
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
212.0
—
0
6
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
6
0.00
0.00
0.0
2.0
—
1.9
—
0
6
(1002224) Polysomnography panel
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6
62
0.96
0.00
1.0
5.0
u/l
318.7
243.9
—
6
57
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
17.4
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
4.0
—
31.9
—
0
7
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: I9_EMBTHROAOR – Embolism and thrombosis of abdominal aorta

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).